We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Acceleron Pharma Inc | NASDAQ:XLRN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 178.75 | 179.92 | 179.91 | 0 | 01:00:00 |
|
|
|
|
|
Delaware
(State or other jurisdiction
of incorporation)
|
|
001-36065
(Commission
File Number)
|
|
27-0072226
(I.R.S. Employer
Identification Number)
|
|
|
|
|
|
128 Sidney Street
Cambridge, MA
(Address of principal
executive offices)
|
|
|
|
02139
(Zip Code)
|
|
|
|
|
|
Exhibit Number
|
|
Description of Exhibit
|
99.1
|
|
Press release of Acceleron Pharma Inc. dated May 8, 2017
|
|
ACCELERON PHARMA INC.
|
|
|
|
|
|
|
|
|
By:
|
/s/ John D. Quisel, J.D., Ph.D.
|
|
|
John D. Quisel, J.D., Ph.D.
|
|
|
Senior Vice President and General Counsel
|
|
|
|
Date: May 8, 2017
|
|
|
Exhibit Number
|
|
Description of Exhibit
|
99.1
|
|
Press release of Acceleron Pharma Inc. dated May 8, 2017
|
1 Year Acceleron Pharma Chart |
1 Month Acceleron Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions